PharmAust reappoints Michael Thurn just month after his resignation

PERTH: A Perth clinical-stage biotech firm has reappointed its former chief executive to the top… read more
Cromwell makes city health buy in local return

ADELAIDE: Listed property group Cromwell is tapping investors for a new healthcare fund to acquire… read more